The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global pharmacy automation market reached a value of US$ 5.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2027, exhibiting a CAGR of 8.24% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Pharmacy automation refers to the use of mechanized systems for digitalizing medical and healthcare workflow processes. These systems aid in performing multiple functions to systematize routine tasks and reduce human intervention. Some of these tasks include mixing liquids and powders for compounding, medicine counting, updating customer database and inventory management. They also aid in eliminating errors during packaging and dispensing pharmaceutical products. Pharmacy automation further keeps track of narcotics and other controlled drugs and monitors usage patterns and ensures maximum efficiency in operations.
The increasing need to reduce errors in medical processes, along with the decentralization of pharmacies, represent as the key factors driving the growth of the market. Pharmacy automation is becoming a crucial component of the modern healthcare industry, as they are highly flexible and self-adaptive. For instance, automation machines prevent cross-contamination of medicines through separate storage cells and chutes facility, which facilitates the tracking of lot numbers and expiration dates with bar codes for convenient scanning and stock management. Furthermore, various technological advancements are resulting in higher success rates post-treatment and surgeries, along with the delivery of efficient patient care, which is significantly contributing to the market growth. Also, increasing prevalence of chronic diseases and rising geriatric population across the globe have amplified the need for automated drug dispensing systems in hospitals and pharmacies. Other factors, including the implementation of various government policies to make quality healthcare facilities accessible to all and the utilization of robots for maximizing medical storage and dispensing prescriptions, are projected to drive the market in the coming years.
IMARC Group’s latest report provides a deep insight into the global pharmacy automation market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the pharmacy automation industry in any manner.
IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmacy automation market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, application and end-user.
Breakup by Product Type:
Breakup by Application:
Breakup by End-User:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Baxter International Inc., Becton Dickinson and Company, Capsa Healthcare, Cerner Corp., Kirby Lester LLC, KUKA AG, McKesson Corporation, Omnicell Technologies, RxSafe LLC, Scriptpro LLC, Swisslog Holding AG, Takazono Corp., Talyst LLC, TCGRx Pharmacy Workflow Solutions, Yuyama Co. Ltd., etc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, Application, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico, Argentina, Colombia, Chile, Peru, Turkey, Saudi Arabia, Iran, United Arab Emirates|
|Companies Covered||Baxter International Inc., Becton Dickinson and Company, Capsa Healthcare, Cerner Corp., Kirby Lester LLC, KUKA AG, McKesson Corporation, Omnicell Technologies, RxSafe LLC, Scriptpro LLC, Swisslog Holding AG, Takazono Corp., Talyst LLC, TCGRx Pharmacy Workflow Solutions and Yuyama Co. Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at